Evidence map›Paper›PMID 31646130›Full record

ReviewCardiovascular endocrinology2017

Cardiovascular disease risk reduction in diabetes through conventional and natural approaches.

William M Schultz, Elliot N Mahlof, Devinder S Dhindsa, Tina Varghese, Robert E Heinl, Hannah C Cai, Pratik B Sandesara, Danny J Eapen, Laurence S Sperling

Abstract readReview
In one paragraph

Review in Cardiovascular endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

William M SchultzDepartment of Medicine, Emory University School of Medicine.
Elliot N MahlofDepartment of Medicine, Emory University School of Medicine.
Devinder S DhindsaDepartment of Medicine, Emory University School of Medicine.
Tina VargheseDepartment of Medicine, Emory University School of Medicine.
Robert E HeinlDepartment of Medicine, Emory University School of Medicine.
Hannah C CaiEmory University.
Pratik B SandesaraDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, USA.
Danny J EapenDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, USA.
Laurence S SperlingDepartment of Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, USA.
Emory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (DM) is a significant cause of premature complications and mortality in patients with cardiovascular disease (CVD). In addition to lifestyle modifications, conventional treatment of DM consists of oral hypoglycemic agents, insulin sensitizers, and subcutaneous insulin. In diabetic individuals with or at risk for CVD, aspirin and statin therapy reduce CVD morbidity and mortality. Several natural or herbal supplements have shown potential benefit in patients with CVD and DM. We provide an overview of the current guidelines for treatment of DM and CVD. We then review the literature to describe the efficacy of natural approaches to CVD risk reduction in diabetic patients, with a focus on physical activity, dietary modification, and natural/herbal supplements. Activity and diet improve cardiovascular outcomes in patients with CVD and DM. Natural and herbal supplements have potential for benefit but require further research to determine their efficacy and safety.

Indexed as

cardiovascular diseasediabetes mellitusherbal supplementsnatural products

Identifiers

PMID31646130
PMCPMC6768523
OpenAlexW2765350077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.